SPIRONOLACTONE\TORSEMIDE: 74 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
74
Total FAERS Reports
19 (25.7%)
Deaths Reported
22
Hospitalizations
74
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities
First Report: 20140101 · Latest Report: 20250701
What Are the Most Common SPIRONOLACTONE\TORSEMIDE Side Effects?
#1 Most Reported
Coronary artery disease
13 reports (17.6%)
#2 Most Reported
Dyspnoea
10 reports (13.5%)
#3 Most Reported
Myocardial infarction
9 reports (12.2%)
All SPIRONOLACTONE\TORSEMIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Coronary artery disease | 13 | 17.6% | 1 | 3 |
| Dyspnoea | 10 | 13.5% | 0 | 1 |
| Asthenia | 9 | 12.2% | 0 | 3 |
| Myocardial infarction | 9 | 12.2% | 5 | 1 |
| Death | 8 | 10.8% | 8 | 2 |
| Chest pain | 7 | 9.5% | 0 | 3 |
| Cough | 7 | 9.5% | 0 | 2 |
| Cardiac disorder | 5 | 6.8% | 0 | 3 |
Who Reports SPIRONOLACTONE\TORSEMIDE Side Effects? Age & Gender Data
Gender: 55.6% female, 44.4% male. Average age: 59.1 years. Most reports from: IN. View detailed demographics →
Is SPIRONOLACTONE\TORSEMIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 1 | 0 | 0 |
| 2017 | 1 | 0 | 0 |
| 2022 | 1 | 0 | 0 |
| 2023 | 7 | 5 | 2 |
| 2024 | 39 | 9 | 13 |
| 2025 | 8 | 1 | 2 |
What Is SPIRONOLACTONE\TORSEMIDE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 54 |
| Diuretic therapy | 5 |
Official FDA Label for SPIRONOLACTONE\TORSEMIDE
Official prescribing information from the FDA-approved drug label.